Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Surveillance Study to Detect Antimalarial Drug Resistance, Gene Deletions of Diagnostic Relevance and Genetic Diversity of Plasmodium Falciparum in Mozambique

NCT05306067 is registered in ClinicalTrials.gov with Centro de Investigacao em Saude de Manhica as lead sponsor.

NCT NCT05306067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05306067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Surveillance Study to Detect Antimalarial Drug Resistance, Gene Deletions of Diagnostic Relevance and Genetic Diversity of Plasmodium Falciparum in Mozambique
Lead sponsor
Centro de Investigacao em Saude de Manhica
Phase
Observational
Overall status
Completed
Start date
October 12, 2021
Completion date
March 31, 2024
Enrollment
21,848 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, malaria in pregnancy, malaria,falciparum